dosing semaglutide compound Dosage Guide for Weight Loss Semaglutide/Glycine/B12 | Strive Pharmacy

Granger, MD, a cardiologist at Duke Health in Durham, North Carolina

In clinical trials, people using GLP-1 drugs lost an average of about 10 pounds more than people using a placebo

The reductions noted in this trial, the team noted, were associated with long-term reductions in alcohol-related negative consequences, improvement in mental health, and aligns with improvement in self-evaluated general and psychological health in the semaglutide group in the trial, although these improvements were modest. The most common adverse effects reported were gastrointestinal, and were more frequent in the semaglutide group, but most were short-lived, and none were severe

Side effects are common in the first week of GLP-1 treatment as your body adjusts to the drug

For researchers monitoring cardiovascular markers, this is worth tracking